Pyxis Oncology (PYXS) EPS (Basic) (2020 - 2026)
Pyxis Oncology's (PYXS) quarterly EPS (Basic) came in at -$0.4 in Q2 2026, down 33.62% year-over-year from -$0.6 in Q2 2025, and down 8023.39% quarter-over-quarter from -$0.0 in Q4 2025.
Analysis
Pyxis Oncology (PYXS) EPS (Basic) (2020 - 2026) Analysis & Trends
Pyxis Oncology (PYXS) has reported EPS (Basic) for 7 consecutive years, with -$0.4 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EPS (Basic) fell 33.62% year-over-year to -$0.4 in Q2 2026; TTM through Jun 2026 was -$1.03, a 34.02% increase from a year earlier, with the FY2025 full-year figure at -$0.99, up 24.82% from the prior year.
- EPS (Basic) was -$0.4 for Q2 2026 at Pyxis Oncology, down from -$0.0 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.0 in Q4 2025 and troughed at -$1.09 in Q4 2022.
- A 5-year average of -$0.49 and a median of -$0.41 in 2023 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 99.2% in 2025, down 354.64% in 2025.
- Over 5 years, EPS (Basic) stood at -$1.09 in 2022, then jumped by 62.92% to -$0.41 in 2023, then sank by 50.17% to -$0.61 in 2024, then soared by 99.2% to -$0.0 in 2025, then plunged by 8023.39% to -$0.4 in 2026.
- The last three EPS (Basic) figures came in at -$0.4 (Q2 2026), -$0.0 (Q4 2025), and -$0.35 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.12 Bn | 192.13 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 180.16 Bn | 176.98 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.52 Bn | 123.67 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.95 Bn | 73.96 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.36 Bn | 55.18 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 53.81 Bn | 48.67 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.01 Bn | 29.70 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.96 Bn | 30.67 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.25 Bn | 29.25 Bn | 1.16 Mn | -0.40 |
| 10 | Pyxis Oncology | 208.29 Mn | 175.30 Mn | - | -0.40 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.40 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | -0.35 |
| Jun 30, 2025 | -0.30 |
| Mar 31, 2025 | -0.36 |
| Dec 31, 2024 | -0.61 |
| Sep 30, 2024 | -0.35 |
| Jun 30, 2024 | -0.29 |
| Mar 31, 2024 | -0.08 |
| Dec 31, 2023 | -0.41 |
| Sep 30, 2023 | -0.57 |
| Jun 30, 2023 | -0.43 |
| Mar 31, 2023 | -0.55 |
| Dec 31, 2022 | -1.09 |
| Sep 30, 2022 | -0.85 |
| Jun 30, 2022 | -0.79 |
| Mar 31, 2022 | -0.97 |
| Dec 31, 2021 | -1.93 |
| Sep 30, 2021 | -7.34 |
| Jun 30, 2021 | -4.03 |